OLIGOCREATOR
Live / Applied — Non-final action mailed (as of 07 Oct 2025)
What this means for you
Not registered yet, but its 19 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79426139
- Mark type
- Design + words
- Filed
- 19 Mar 2025
Goods and services
- Class 042 — Scientific and technological services: Scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; bioinformatic services for the pharmaceutical and biotechnological industry; services for evaluating the efficacy and safety of pharmaceutical products.
- Class 044 — Medical, beauty and agricultural services: Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, in relation to the development of pharmaceutical products; consultancy services to third parties in relation to the evaluation of safety and efficacy of pharmaceuticals.
- Class 045 — Legal and security services: Licensing of industrial property rights arising from scientific research services in the field of biochemistry [excluding the field of cell culture products], nucleic acids and bioinformatics, in particular molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the design of pharmaceutical active ingredients by means of the aforementioned processes and techniques, including the use of bioinformatics techniques; licensing of industrial property rights arising from the development of pharmaceutical products by means of the aforementioned processes and techniques, including the use of bioinformatics techniques, including the performance of associated testing and diagnostic procedures; licensing of industrial property rights arising from bioinformatic services for the pharmaceutical and biotechnological industry; licensing of industrial property rights arising from the services for evaluating the efficacy and safety of pharmaceutical products.
Owner
Prosecution history
- 24 Oct 2025 — REFUSAL PROCESSED BY IB
- 07 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 07 Oct 2025 — REFUSAL PROCESSED BY MPU
- 23 Aug 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 22 Aug 2025 — NON-FINAL ACTION WRITTEN
- 19 Aug 2025 — ASSIGNED TO EXAMINER
- 23 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 23 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Jun 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB